NDA (New Drug Application)
ANDA (Generic Application)
Track protection status across key markets to assess launch feasibility.
It is formulated by 1 pharmaceutical company such as MAYNE PHARMA. It is marketed under 1 brand name, including ANNOVERA. Available in 1 different strength, such as 0.013MG/24HR;0.15MG/24HR, and administered through 1 route including RING;VAGINAL.
API availability: Loading API feasibility...
Licensing: 1 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
| Strength | Route of Administration | Companies | Latest Approval Date |
|---|
Patents approved by the FDA for the ingredient
|
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
|---|---|---|---|---|---|
| {"application_id":"69969","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"7f53f3ba4a1b4d30b3c0","publication_number":"US10632066B1","cleaned_patent_number":"10632066","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-02-01","publication_date":"2020-04-28","legal_status":"Granted"} | US10632066B2 | 28 Apr, 2020 | Granted | 01 Feb, 2039 | |
| {"application_id":"69970","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"7f53f3ba4a1b4d30b3c0","publication_number":"US10765628B2","cleaned_patent_number":"10765628","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-02-01","publication_date":"2020-09-08","legal_status":"Granted"} | US10765628B2 | 08 Sep, 2020 | Granted | 01 Feb, 2039 | |
| {"application_id":"69971","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"7f53f3ba4a1b4d30b3c0","publication_number":"US10780047B2","cleaned_patent_number":"10780047","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-02-01","publication_date":"2020-09-22","legal_status":"Granted"} | US10780047B2 | 22 Sep, 2020 | Granted | 01 Feb, 2039 | |
| {"application_id":"69973","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"b856a4fa29d248548620","publication_number":"US10918649B2","cleaned_patent_number":"10918649","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-06-21","publication_date":"2021-02-16","legal_status":"Granted"} | US10918649B2 Formulation | 16 Feb, 2021 | Granted | 21 Jun, 2039 | |
| {"application_id":"69983","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"b856a4fa29d248548620","publication_number":"US10925882B2","cleaned_patent_number":"10925882","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-06-21","publication_date":"2021-02-23","legal_status":"Granted"} | US10925882B2 Formulation | 23 Feb, 2021 | Granted | 21 Jun, 2039 | |
| {"application_id":"69984","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"b856a4fa29d248548620","publication_number":"US10940157B2","cleaned_patent_number":"10940157","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-06-21","publication_date":"2021-03-09","legal_status":"Granted"} | US10940157B2 Formulation | 09 Mar, 2021 | Granted | 21 Jun, 2039 | |
| {"application_id":"69985","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"cf537c02ac754186b9cb","publication_number":"US11529308B2","cleaned_patent_number":"11529308","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-06-21","publication_date":"2022-12-20","legal_status":"Granted"} | US11529308B2 Formulation | 20 Dec, 2022 | Granted | 21 Jun, 2039 | |
| {"application_id":"69986","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"b856a4fa29d248548620","publication_number":"US11850251B2","cleaned_patent_number":"11850251","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-06-21","publication_date":"2023-12-26","legal_status":"Granted"} | US11850251B2 | 26 Dec, 2023 | Granted | 21 Jun, 2039 | |
| {"application_id":"69987","ingredient":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","trade_name":"ANNOVERA","family_id":"b856a4fa29d248548620","publication_number":"US20220054503A1","cleaned_patent_number":"12303518","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-06-21","publication_date":"2022-02-24","legal_status":"Pending"} | US12303518B2 Formulation | 24 Feb, 2022 | Pending | 21 Jun, 2039 |
Latest clinical trials and research studies for this ingredient
| NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
|---|
Manufacturing Locations
Unlock access to all suppliers of Ethinyl Estradiol; Segesterone Acetate
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.